Cabaletta Bio (CABA) Non-Current Assets (2018 - 2025)
Cabaletta Bio's (CABA) quarterly Non-Current Assets came in at $26.2 million in Q4 2025, up 42.68% year-on-year from $18.4 million in Q4 2024, and up 4.02% quarter-over-quarter from $25.2 million in Q3 2025.
Cabaletta Bio (CABA) Non-Current Assets (2018 - 2025) Analysis & Trends
Cabaletta Bio's Non-Current Assets history runs 8 years deep, the most recent figure standing at $26.2 million for Q4 2025.
- On a quarterly basis, Non-Current Assets rose 42.68% year-over-year to $26.2 million in Q4 2025; TTM through Dec 2025 was $108.0 million, a 75.96% increase from a year earlier, with the FY2025 full-year figure at $26.2 million, up 42.68% from the prior year.
- Non-Current Assets climbed to $26.2 million in Q4 2025 per CABA's latest filing, from $25.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $30.5 million in Q1 2025 and bottomed at $1.5 million in Q1 2021.
- The 5-year median for Non-Current Assets is $7.9 million (2022), against an average of $11.2 million.
- Across the five-year window, Non-Current Assets plunged 56.74% in 2021 and surged 353.15% in 2022, its largest moves.
- Year by year, Non-Current Assets stood at $1.8 million in 2021, then jumped by 353.15% to $8.1 million in 2022, then rose by 12.61% to $9.2 million in 2023, then jumped by 100.56% to $18.4 million in 2024, then jumped by 42.68% to $26.2 million in 2025.
- Per Business Quant, the three latest CABA Non-Current Assets figures stand at $26.2 million (Q4 2025), $25.2 million (Q3 2025), and $26.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Cabaletta Bio | 182.04 Mn | 182.04 Mn | - | 26.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.21 Mn |
| Sep 30, 2025 | 25.20 Mn |
| Jun 30, 2025 | 26.09 Mn |
| Mar 31, 2025 | 30.55 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Sep 30, 2024 | 18.90 Mn |
| Jun 30, 2024 | 11.16 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 9.16 Mn |
| Sep 30, 2023 | 7.11 Mn |
| Jun 30, 2023 | 7.07 Mn |
| Mar 31, 2023 | 7.71 Mn |
| Dec 31, 2022 | 8.13 Mn |
| Sep 30, 2022 | 3.50 Mn |
| Jun 30, 2022 | 3.27 Mn |
| Mar 31, 2022 | 2.22 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Sep 30, 2021 | 1.79 Mn |
| Jun 30, 2021 | 1.92 Mn |
| Mar 31, 2021 | 1.53 Mn |